Key Metrics
5.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.86
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Internal Medicine
SJR
- Q2 Internal Medicine
- Q2 Endocrinology, Diabetes and Metabolism
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.01
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
72%
4 to 6 months
26%
7 to 9 months
1%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Body mass index
- Type 2 Diabetes Mellitus
- Type 2 diabetes
- Hypoglycemia
- Renal function
- Observational study
- Randomized controlled trial
- Myocardial infarction
- Continuous glucose monitoring
- Diabetic nephropathy
- Insulin resistance
- Quality of life
- Basal insulin
- Semaglutide
- Metformin
- Sitagliptin
- Oxidative stress
- Confidence interval
- Liver failure
- Emergency department
Journal Specifications
| Overview | |
| Publisher | SPRINGER HEIDELBERG |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Diabetes Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Oral Semaglutide Use in Type2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies.
- 13 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
-
Full paper
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type2 Diabetes are Independent of Baseline Characteristics.
- 12 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
-
Full paper
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN6 and PIONEER6.
- 9 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
-
Full paper
Cardiovascular Health Metrics of Spouses of Indian Women with a History of Gestational Diabetes and Diabetes in Pregnancy: Results from CHIP-F Study.
- 9 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
-
Full paper
Publisher Correction to: Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion.
- 9 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
-
Full paper
Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes.
- 2 Nov 24
- Diabetes therapy : research, treatment and education of diabetes and related disorders
Scite analysis
Powered by scite_
1.7k articles received 23.6k citations see all
- 1,416 Supporting
- 21,149 Mentioning
- 190 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 48 Corrections
- 58 Errata
- 0 Expression of Concern
FAQs
How long has Diabetes Therapy been actively publishing?
Diabetes Therapy has been in operation since 2010 till date.
What is the publishing frequency of Diabetes Therapy ?
Diabetes Therapy published with a Bi-monthly frequency.
How many articles did Diabetes Therapy publish last years ?
In 2023, Diabetes Therapy published 159 articles.
What is the eISSN & pISSN for Diabetes Therapy ?
For Diabetes Therapy,eISSN is 1869-6961 and pISSN is1869-6953.
What is Citescore for Diabetes Therapy ?
Citescore for Diabetes Therapy is 5.1.
What is SNIP score for Diabetes Therapy ?
SNIP score for Diabetes Therapy is 1.01.
What is the SJR for Diabetes Therapy ?
SJR for Diabetes Therapy is Q2.
Who is the publisher of Diabetes Therapy ?
SPRINGER HEIDELBERG is the publisher of Diabetes Therapy.